Operating partners see AI from a different angle than practice leaders. The question is not only "will this help one company?" but "can we deploy it across the portfolio, govern it, and show results to the investment committee?"
This guide covers how to evaluate an AI agent platform for PE-backed healthcare from that seat. For how AI expands EBITDA at the portfolio level, see our PE portfolio guide.
Five Questions for the Operating Partner
1. Can it be deployed as a repeatable playbook?
The same deployment approach should work at a dental platform, a dermatology platform, and a PT platform, with specialty configuration rather than a new project each time.
2. Can management teams own it?
The operating partner sponsors; the portfolio company's COO runs it. The platform should be usable by operators, not only by technical teams.
3. Is governance centralized?
Role-based access, audit logs, a signed BAA, encryption, and security documentation that can pass each portfolio company's review, and later a buyer's diligence.
4. Does it report in board language?
Fill rate, retention, cost per appointment, and EBITDA by location, not message counts. Results should roll up cleanly into the monthly operating review.
5. Does it make exits easier?
Standardized operations and clean, comparable data across locations support a stronger story in diligence.
| Operating partner need | Point AI tools | AI agent platform |
|---|---|---|
| Portfolio-wide playbook | Different tool per company | One repeatable deployment |
| Governance | Vendor by vendor | Centralized |
| Board reporting | Activity metrics | Location-level outcomes |
| Add-on onboarding | New tools per site | Joins existing platform |
| Exit readiness | Fragmented data | Consistent operating history |
A Portfolio Deployment Sequence
- Pilot at one portfolio company, on a few locations, with a clear baseline
- Prove results against agreed metrics within one or two quarters
- Standardize the playbook and roll out across that company's locations
- Replicate at other healthcare portfolio companies, adapted by specialty
- Report in the same format across the portfolio
How Samara Supports Operating Partners
Samara AI Teams (AIT) provides the AI agent workforce, and Samara AI Platform (AIP) the integration and data layer, designed for PE-backed outpatient platforms across specialties. Visit our private equity page or Book a demo.
Frequently Asked Questions
Why should a PE firm standardize on one AI agent platform?
It creates a repeatable value creation playbook, one governance model, and consistent reporting across portfolio companies.
Who should own the AI platform at the portfolio company?
The operating partner sponsors it, and the portfolio company's operations leadership owns deployment and results.
How should results be reported to the board?
As location-level operating outcomes, such as fill rate, retention, and cost per appointment, rolled up to EBITDA impact.